The company said, “The Company is increasing full-year 2025 Adjusted EBITDA guidance to $115.0 – 120.0 million and projected full-year 2025 Modern Oral sales to $125.0 – 130.0 million.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TPB: